Collectively, these results indicated that CaA inhibited the activity of mortalin by both transcriptional (indirectly, via blocking NF-κB) and posttranscriptional (directly, via targeting and inducing the ubiquitin-mediated degradation of mortalin) modifications in HCC cells. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.